3 active not recruiting, 3 completed, 1 enrolling by invitation. 5 Phase 2, 4 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Active not recruiting 2 |
| Phase 3 | 4 | Active not recruiting 2, Completed 1, Enrolling by invitation 1 |
| Phase 1 | 1 | Completed 1 |
Follow JR-141: new trials by email Literature Review of JR-141 trials Research Report on JR-141
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in MPS II (Hunter Syndrome) Subjects JR-141 - Mucopolysaccharidosis II | Phase 3 | Enrolling by invitation | JCR Pharmaceuticals Co., Ltd. | 80 | 2023-02-22 | 2026-01-21 |
| A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT) JR-141, Idursulfase, JR-141 or Idursulfase - Mucopolysaccharidosis II | Phase 3 | Active not recruiting | JCR Pharmaceuticals Co., Ltd. | 86 | 2022-02-14 | 2026-10-02 |
| An Extension Study of JR-141 in Patients With Mucopolysaccharidosis Type II JR-141 - Mucopolysaccharidosis II | Phase 2 / Phase 3 | Active not recruiting | JCR Pharmaceuticals Co., Ltd. | 27 | 2019-09-01 | 2026-09-03 |
| An Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis II JR-141 - Mucopolysaccharidosis II | Phase 2 | Active not recruiting | JCR Pharmaceuticals Co., Ltd. | 19 | 2019-01-01 | 2026-09-08 |
| A Study of JR-141 in Patients With Mucopolysaccharidosis II JR-141 - Mucopolysaccharidosis II | Phase 2 / Phase 3 | Completed | JCR Pharmaceuticals Co., Ltd. | 28 | 2018-08-01 | 2022-11-14 |
| A Study of JR-141 in Patients With Mucopolysaccharidosis II (BR21) JR-141 - Mucopolysaccharidosis II | Phase 2 | Completed | JCR Pharmaceuticals Co., Ltd. | 18 | 2018-07-26 | 2025-07-24 |
| A Study of JR-141 in Patients With Mucopolysaccharidosis Type II JR-141 - Mucopolysaccharidosis II | Phase 1 / Phase 2 | Completed | JCR Pharmaceuticals Co., Ltd. | 14 | 2017-03-30 | 2022-11-14 |
JCR Pharmaceuticals Co., Ltd. (7)
Brazil (4) · Japan (3) · Argentina (2) · France (2) · Germany (2) · Italy (2) · Poland (2) · Spain (2) · United States (2) · Colombia (1) · Israel (1) · Turkey (Türkiye) (1) · United Kingdom (1)